Translink Corporate Finance Israel acted as exclusive advisor to Gal-Kal, a leading Israeli provider of accessibility and rehabilitation solutions, on the sale to Chemitec, a healthcare company specialising in the import, distribution, and marketing of medical and assistive products.
Translink Corporate Finance Switzerland advised Institut für histologische und zytologische Diagnostik AG Aarau on the sale to Affidea Group (Affidea). This acquisition adds two high-quality pathology laboratories – one in Zollikon next to Zürich, close to Affidea’s Centre of Excellence in Breast Cancer, Brust-Zentrum Zurich, and another one in Aarau, Argovia.
Translink Corporate Finance in Denmark acted as the M&A advisor to the owners of Mathot on the sale to Mediq.
The cross-border team led by Henrik Schrøder and Jens Borelli-Kjaer from Denmark, and Thomas Hesseling from the Netherlands acted as the M&A advisor the owners of Mathot on the sale to Mediq, a reliable partner for patients, healthcare organisations and health insurers, with a focus on improving healthcare outcomes and the affordability of healthcare.
Translink Corporate Finance in Germany advised Marinomed Biotech AG, a renowned biopharmaceutical company in the field of respiratory diseases listed on the Vienna Stock Exchange, on the sale of its Carragelose portfolio to Unither Pharmaceuticals SAS.
Translink Corporate Finance in the United States initiated the acquisition of Nostalgia Group, Inc., a community and residential services provider to adults with developmental disabilities,
by Support, Inc., a portfolio company of Petra Capital Partners.
Translink Corporate Finance in the United States advised IRN Home Care in its sale to Honor Health Network (Honor), a portfolio company of Webster Equity Partners. Honor is a portfolio company of Webster Equity Partners. IRN Home Care is a premier provider of non-medical home care services in the greater Denver, Colorado area.
Translink Corporate Finance in the United Kingdom advised shareholders of Riverside Medical Packaging, a leading supplier of sterilisation packaging systems and services on the sale to Sterimed, a world leader in medical packaging.
Translink Corporate Finance in The Netherlands advised UD-Vet, a leading provider of veterinary practice equipment and other veterinary imaging modalities, on the sale to IMV Technologies, a global leader in animal artificial insemination and veterinary imaging.
Translink Corporate Finance in the United States initiated the acquisition of Clintrex Research Corporation by ToxStrategies, a best-in-class, multidisciplinary scientific consulting firm.
Translink Corporate Finance in the United States advised SignatureCare Emergency Center (SignatureCare) based in Houston, Texas, on the sale of a Free-Standing Emergency Department (FSED) in Paris, Texas, to Lifepoint Healthcare, a portfolio company of Apollo Global Management (NYSE: APO). Dinan served as exclusive financial advisor to SignatureCare and its affiliates in this transaction.
